禁酒对阿拉斯加巴罗的门诊病人的影响,阿拉斯加州巴罗
相关实验视频
Updated: Jul 20, 2026

10:29
The FlyBar: Administering Alcohol to Flies
Published on: May 18, 2014
A Y Chiu1, P E Perez, R N Parker
1North Slope Borough Physician Services, Barrow, Alaska, USA.
JAMA
|December 5, 1997
概括
在一个孤立的阿拉斯加社区,实施酒精禁令显著减少了因酒精相关问题的门诊访问. 取消禁令导致访问增加,证明酒精禁令.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生政策 卫生政策
背景情况:
- 社区的酒精供应影响了消费和相关的危害.
- 阿拉斯加巴罗在33个月的时间里经历了波动的酒精政策:合法,禁止,合法,禁止.
研究的目的:
- 评估酒精政策变化对阿拉斯加巴罗州酒精相关问题的门诊访问的影响.
主要方法:
- 对医院门诊病人的病历进行回顾性分析.
- 时间序列分析,将酒精政策的变化与访问频率相关联.
主要成果:
- 酒精禁令与与酒精有关的门诊诊次数显著减少有关.
- 取消禁令导致访问量增加;重新实施禁令减少了访问量.
- 统计分析证实了政策变化的重大影响 (P<.05).
结论:
- 禁酒可以作为一个有效的公共卫生干预在孤立的社区.
- 政策干预可以明显减少与酒精有关的健康问题.
相关概念视频
SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Diagnosing Acidosis and Alkalosis
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and HCO3− values are examined to...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and HCO3− values are examined to...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

